Three companies priced US IPOs last week, while one was delayed and two, including Votorantim Cimentos (VEBM), the largest expected deal of 2013 year-to-date, were postponed. Two biotechs, bluebird bio (BLUE) and PTC Therapeutics (PTCT), priced upsized...read more
Gogo, a leading provider of in-flight WiFi on commercial and business jets, raised $187 million by offering 11.0 million shares at $17, the high end of the range of $15 to $17. Gogo plans to list on the NASDAQ under the symbol GOGO. Morgan Stanley, J.P. Morgan...read more
For the fifth consecutive week, at least one US IPO gained 30%, as Gigamon (GIMO) climbed nearly 50%. The week's most prominent IPO, Coty (COTY), faltered though, and the third scheduled deal, Aratana Therapeutics (PETX) was delayed. Nine more IPOs,...read more
US IPO Recap: Biotech success continues, but three deals delayed or postponed
Three companies priced US IPOs last week, while one was delayed and two, including Votorantim Cimentos (VEBM), the largest expected deal of 2013 year-to-date, were postponed. Two biotechs, bluebird bio (BLUE) and PTC Therapeutics (PTCT), priced upsized...read more
Gogo prices IPO at $17, the high end of the range
Gogo, a leading provider of in-flight WiFi on commercial and business jets, raised $187 million by offering 11.0 million shares at $17, the high end of the range of $15 to $17. Gogo plans to list on the NASDAQ under the symbol GOGO. Morgan Stanley, J.P. Morgan...read more
US IPO Recap: Coty fades, Gigamon springs and 17 companies file or set terms
For the fifth consecutive week, at least one US IPO gained 30%, as Gigamon (GIMO) climbed nearly 50%. The week's most prominent IPO, Coty (COTY), faltered though, and the third scheduled deal, Aratana Therapeutics (PETX) was delayed. Nine more IPOs,...read more
6 US IPOs planned for the week of Jun 17
The following IPOs are expected to price this week: Aratana Therapeutics (PETX), which is developing medications for cats and dogs based on therapies for humans, plans...read more